Denmark
Novo Nordisk To Slash Prices On Buzzy Drugs Ozempic and Wegovy
Novo Nordisk, the Danish maker of the injectable diabetes drug Ozempic and its sister weight-loss medicine Wegovy, is planning to slash prices amid both shortages and increasing competition. Novo CEO Karsten Munk Knudsen, as Reuters reports, conceded
Related
Share this page
Guest Posts by Easy Branches